Pityriasis rubra pilaris developing after COVID-19

Abstract

Coronavirus disease-2019 (COVID-19) has been associated with multiple skin lesions as well as causing common respiratory symptoms. We presented a case of pityriasis rubra pilaris that developed after COVID-19 infection and treated with anti-tumor necrosis factor (adalimumab), which was not previously reported in an adult.

Keywords

• pityriasis rubra pilaris
• covid-19
• skin
• viral infection
• treatment
• anti-tnf